Skip to main content
. 2017 Sep 15;8(49):86020–86030. doi: 10.18632/oncotarget.20902

Figure 2. miR-20a, miR-30d and miR-494 relative expression in discovery and replication groups.

Figure 2

Expression level of miR-20a, miR-30d and miR-494 in testing (NanoString) and validation (RT-PCR) groups. MiR-20a and miR-30d were found to be significantly upregulated in the CNS relapse group by NanoString analysis and these results were validated by testing additional samples using RT-PCR. MiR-494 was not significantly different when testing additional samples. Data are represented as mean +/- SEM.*<0.05